Cost-effectiveness Analysis on 5 Drug Treatment Schemes in the Treatment of Acute Pancreatitis
- VernacularTitle:急性胰腺炎5种药物治疗方案的成本-效果分析
- Author:
Weiran ZHOU
- Publication Type:Journal Article
- Keywords:
Acute pancreatitis;
Pharmacoeconomics;
Cost-effectiveness analysis
- From:
China Pharmacy
2001;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the cost-effectiveness of5kinds of drug treatment regimes in the treatment of ac_ ute pancreatitis.METHODS:The cost-effectiveness method in pharmacoeconomics was adopted in the retrospective analysis of the following5treatment schemes:octreotide in group A,ulinastatin in group B,fluorouracil in group C,nifedipine in group D and rhei decoction in group E.RESULTS:The costs for the5treatment schemes were2678.24,3071.68,1101.70,1089.04,and1098.04yuan respectively;The effective rates of the5schemes were96.88%,93.55%,92.86%,92.00%and96.55%respectively;The cost effectiveness ratio of schemes E was the minimum,which was11.53yuan;On the basis of group D,the superaddition costs for gaining one effectiveness unit for scheme A,B,C and E were324.33,1321.76,14.07,1.96yuan respectively.CONCLUSIONS:Among the5schemes,scheme E was the best one.
